Category: Washington, D.C.

The D.C. Alcoholic Beverage and Cannabis Board has denied DC Dank’s request to reconsider the rescission of its medical cannabis retailer application, finding the proposed dispensary location falls within the District’s mandatory 400-foot buffer from a school.

D.C. medical cannabis patients and sales hit record highs in May 2026, per ABCA’s latest program metrics report.

District regulators closed three unlicensed cannabis storefronts in Washington, D.C., between late May and mid-June, seizing marijuana, THC products and psilocybin mushrooms while arresting six individuals. The actions bring the total number of illicit cannabis businesses shuttered under the District’s expanded enforcement law to 113.

The D.C. Council will hold a public hearing on July 2 for three medical cannabis bills that would extend conditional licenses, allow dispensaries to prepare certain cannabis products on-site, and create a new endorsement for cannabis-infused beverage production.

D.C. cannabis regulators are seeking to deny a medical cannabis retailer license for Aloha, alleging owner Saleh Salim was involved in illegal cannabis operations and is facing pending criminal charges in Virginia. The proposed order cites prior enforcement actions tied to businesses associated with Salim and questions whether he meets the character requirements necessary to…

After a coordinated lobbying effort involving cannabis operators and advocates, a proposed increase in D.C.’s medical cannabis tax rate appears to have been removed from the budget package headed for a Council vote. Industry leaders argued the increase would have harmed businesses already facing intense market pressures.

The D.C. Alcoholic Beverage and Cannabis Board ruled that daycare centers do not qualify as preschools under current cannabis zoning law, allowing Exotix DMV to move forward with a medical cannabis retailer license in Northwest Washington.

The Alliance for Recreational Cannabis Entities and the District of Columbia jointly dismissed a federal lawsuit challenging D.C.’s cannabis licensing framework. The dismissal was filed without prejudice, meaning the claims could be refiled later, and comes shortly after D.C. cited a federal appeals court ruling supporting its defense against dormant Commerce Clause claims.

The D.C. Cannabis Board approved a settlement requiring West2East/Blossomz to pay a $10,000 fine, remain under closure, and sell its cultivation license within 90 days or face revocation following its February shutdown.